News & Analysis on Clinical Trial Services & Contract Research And Development
Last week's approval of Erbitux in the US breaks a 30-year drought in treatments for head and neck cancer, a disease that kills 11,000 people in the US each year. Pharma giant Bristol-Myers Squibb (BMS) and biotech company ImClone Systems are poised...
Stericycle, the largest provider of medical waste management services in the US, has stretched its reach across the Atlantic, completing the acquisition of Ireland's Sterile Technologies Group.
British equipment supplier Isopak has launched a new pharmaceutical dosing filler system for powders and granules, quickly and accurately offering the doses required.
Japan's fourth-largest pharmaceutical company, Eisai, has announced plans for a new pharmaceutical production and formulation research and development facility in North Carolina in anticipation of its parenteral and intravenous oncology treatments.
Life sciences firm Cambrex has reported a $140.3m (€116.7m) loss in Q4 as opposed to a profit of $4.9m in Q4 last year, hit by lower long-term profitability projections for its Biopharma unit, as biotech companies seem to lose their appetite for...